Photodynamic inactivation using curcumin shows promise in reducing antibiotic resistance diversity in Staphylococcus aureus, ...

AbbVie has announced that the US Food and Drug Administration (FDA) has approved its Pfizer-partnered Emblaveo ...

D illustration of bacteriaphages attacking bacteria. Courtesy Getty Images.In the face of rising concerns about antibiotic ...

The Harvard Pilgrim Health Care Institute is proud to announce the launch of the Center for Sepsis Epidemiology and ...

Emblaveo marks the first and only fixed-dose intravenous monobactam/β-lactamase inhibitor combination antibiotic to be ...

For the full year 2024, Navamedic ASA (OSE: NAVA), a Nordic pharma company and reliable provider of high-quality products to hospitals and pharmacies, delivered revenues of NOK 531.3, which is 3.8 per ...

In an interview with The American Journal of Managed Care, Michael A. Bernstein, MD, stressed the need for effective ...

More than 26,000 people are hospitalized by the bacterial infection each year in the U.S., and 420 people die, according to ...

While the Nationalist Party said it welcomes the fact that the Government has finally published a National Strategy on Sexual Health for public consultation, it notes that this has come far too late.

Pearl Diagnostics will receive $1 million to evaluate the potential of a prototype assay for early detection of pneumonia caused by Pseudomonas aeruginosa.

Today the Coalition for Epidemic Preparedness Innovations (CEPI) announced an award of $5 million funding award to Ethris, a ...